We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$14.4B
AUM Growth
+$892M
Cap. Flow
-$156M
Cap. Flow %
-1.09%
Top 10 Hldgs %
18.69%
Holding
398
New
20
Increased
86
Reduced
202
Closed
16

Top Buys

Rank Stock Value
1
CFR icon
Cullen/Frost Bankers
CFR
+$105M
2
SMPL icon
Simply Good Foods
SMPL
+$78.2M
3
ACLS icon
Axcelis
ACLS
+$59.2M
4
MTDR icon
Matador Resources
MTDR
+$59M
5
DLB icon
Dolby
DLB
+$52M

Top Sells

Rank Stock Value
1
JLL icon
Jones Lang LaSalle
JLL
+$90.4M
2
TXRH icon
Texas Roadhouse
TXRH
+$64.4M
3
NTAP icon
NetApp
NTAP
+$55.3M
4
FIX icon
Comfort Systems
FIX
+$32.5M
5
SFM icon
Sprouts Farmers Market
SFM
+$31.1M

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Financials 14.98%
3 Healthcare 14.82%
4 Industrials 13.9%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
251
Pfizer
PFE
$143B
$2.06M 0.01%
71,321
-1,261
-2% -$36.8K
VO icon
252
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$2.03M 0.01%
30,820
VV icon
253
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
$2.01M 0.01%
7,645
INTU icon
254
Intuit
INTU
$86.5B
$1.92M 0.01%
3,091
RY icon
255
Royal Bank of Canada
RY
$291B
$1.9M 0.01%
15,215
+25
+0.2% +$2.87K
PH icon
256
Parker-Hannifin
PH
$123B
$1.86M 0.01%
2,950
SPGI icon
257
S&P Global
SPGI
$121B
$1.85M 0.01%
3,589
+41
+1% +$20.3K
AMCR icon
258
Amcor
AMCR
$20.8B
$1.76M 0.01%
30,984
SAP icon
259
SAP
SAP
$212B
$1.72M 0.01%
7,495
+1,500
+25% +$319K
IWR icon
260
iShares Russell Mid-Cap ETF
IWR
$56B
$1.7M 0.01%
19,325
CMI icon
261
Cummins
CMI
$87.5B
$1.63M 0.01%
5,020
+675
+16% +$200K
BAC icon
262
Bank of America
BAC
$435B
$1.59M 0.01%
39,968
+60
+0.2% +$2.4K
BF.A icon
263
Brown-Forman Class A
BF.A
$13.4B
$1.56M 0.01%
32,400
IVV icon
264
iShares Core S&P 500 ETF
IVV
$878B
$1.54M 0.01%
2,676
+100
+4% +$55.6K
REGN icon
265
Regeneron Pharmaceuticals
REGN
$78.5B
$1.53M 0.01%
1,453
-20
-1% -$22.3K
WM icon
266
Waste Management
WM
$90.6B
$1.46M 0.01%
7,034
-245
-3% -$51.1K
IWM icon
267
iShares Russell 2000 ETF
IWM
$79.8B
$1.4M 0.01%
6,322
+2,385
+61% +$510K
ED icon
268
Consolidated Edison
ED
$40.1B
$1.4M 0.01%
13,398
-40
-0.3% -$3.96K
KMB icon
269
Kimberly-Clark
KMB
$36.3B
$1.39M 0.01%
9,758
NSC icon
270
Norfolk Southern
NSC
$75.4B
$1.36M 0.01%
5,467
-150
-3% -$36K
TGT icon
271
Target
TGT
$65.6B
$1.3M 0.01%
8,328
TMO icon
272
Thermo Fisher Scientific
TMO
$213B
$1.29M 0.01%
2,085
+26
+1% +$15.4K
VUG icon
273
Vanguard Morningstar Growth ETF
VUG
$220B
$1.28M 0.01%
20,004
SNPS icon
274
Synopsys
SNPS
$74.4B
$1.24M 0.01%
2,444
+111
+5% +$59.6K
STT icon
275
State Street
STT
$50.6B
$1.22M 0.01%
13,761
-75
-0.5% -$6.18K

Similar funds

Boston Trust Walden's Q3 2024 Portfolio in Review

As of Q3 2024, Boston Trust Walden held 398 positions worth $14.4B, up 6.6% from $13.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q3 2024 filing shows 20 new, 86 increased, 202 reduced and 16 closed positions. Its largest new stake was Cullen/Frost Bankers: 958,038 shares worth $107M. The largest sale was Jones Lang LaSalle, an estimated $90.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q3 2024 buy was Cullen/Frost Bankers: 958,038 shares worth $107M.
  • Boston Trust Walden added most to Dolby in Q3 2024, an estimated $52M increase.
  • Boston Trust Walden's biggest Q3 2024 reduction was Jones Lang LaSalle, cutting an estimated $90.4M.
  • Boston Trust Walden fully exited Central Garden & Pet Co Class A in Q3 2024, selling an estimated $21.7M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $14.4B portfolio in Q3 2024.
  • Boston Trust Walden opened 20 new positions and closed 16 in Q3 2024.
  • Boston Trust Walden's portfolio value rose 6.6% quarter-over-quarter to $14.4B.

Based on Boston Trust Walden's 13F filing for Q3 2024, filed 24 Oct 2024.